Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. - Test2 - elhamkhani - TriplyDB

Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome.

Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome.

http://www.wikidata.org/entity/Q34606239

about

An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome Inflammation in irritable bowel syndrome: Myth or new treatment target?Diet in irritable bowel syndrome Gut microbiota as potential orchestrators of irritable bowel syndrome Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome.Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome.Analgesic effects of JCM-16021 on neonatal maternal separation-induced visceral pain in rats.Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review).Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome Stomach antral endocrine cells in patients with irritable bowel syndrome.Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome.The role of mast cells in functional GI disorders.Subjective food hypersensitivity: assessment of enterochromaffin cell markers in blood and gut lavage fluid.Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction Recent developments in the pathophysiology of irritable bowel syndrome.Pathophysiologic findings of irritable bowel syndrome in china.Serum and colonic mucosal immune markers in irritable bowel syndrome Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities Irritable bowel syndrome: diagnosis and pathogenesis.Protective Effects of Alisma orientale Extract against Hepatic Steatosis via Inhibition of Endoplasmic Reticulum Stress.Mast Cell-Mediated Mechanisms of Nociception.Analysis of colonic mucosa mast cell count in patients with chronic diarrhea Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome Serotonin in the gastrointestinal tract.The Role of Mast Cells in Irritable Bowel Syndrome.Endocrine cells in the ileum of patients with irritable bowel syndrome.Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?Is irritable bowel syndrome an organic disorder?Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment.Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome.Recent advances in the diagnosis of irritable bowel syndrome.Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome.Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators.The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome.From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases.Early life adversity in piglets induces long-term upregulation of the enteric cholinergic nervous system and heightened, sex-specific secretomotor neuron responses.Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome.

P2860

Q24630575-F32FC8B1-C2B2-476D-83D6-D5020447723F Q26768545-F5C7E6D3-1C0A-4672-BE86-172ECEAB5727 Q26824367-3D5EBB3E-8380-42FB-ADED-5178F24497F0 Q28085584-DCD538E0-FE75-4247-8F9F-5C880B491D3E Q28087731-D0CF78C2-B186-4D6A-B202-C8932FE56811 Q33555354-33238C68-36AF-45B0-A771-B4348EA395FB Q33625633-6E339D23-0974-4C5E-9230-CD32AA0BBD04 Q33672837-C3B8D44D-F89C-4810-B0DB-8B783B8EF95F Q33890272-EAC121AE-4192-443A-A697-922CF6C73FDC Q34105187-3877DBA8-BAAD-48DB-B559-6275E276BB00 Q34121823-355FC36D-055B-44A1-B650-8B44EB197BDA Q34425563-0CE872F8-6494-4499-9750-3D822CE5A06C Q34486007-F9F99009-2104-442B-8452-E19821EBC61E Q35178813-0B829D17-7D7E-443A-A0EF-9D0AB0098F4F Q35534031-DAA73E8D-A646-46EB-BA94-3D523E489AFA Q35689193-21AC33DA-DBAF-493E-A472-C12F7AC99C8A Q35730488-06A8D06B-CA25-4C5E-8BE4-A2D2C0C0EEF0 Q35815638-21F52D8F-7A5B-4558-8317-4ED97497ECAA Q35837381-E25527FD-5491-412B-96C5-A069E1B157D7 Q35992392-06FF7887-4DF8-4669-85DA-C81283764D6E Q36310403-9688A000-58C5-45DB-8458-F3A60E6FEF2E Q36324486-FFFD604A-9863-40B3-9873-606674A86B1A Q36404141-4B7F2A41-6B47-4E13-9002-B8F93ABDD9A2 Q36404877-412E5F41-788D-4DBC-900C-E2FD86002BA0 Q37204274-FC950440-F270-47D1-B3ED-ADE547DFCBEC Q37223378-F3D07117-6036-41F9-985C-511EB4F20544 Q37578593-FFC8E895-24C7-4891-9B6F-8BDD28195FE4 Q37617989-A35E34F6-3F75-4D42-9C22-CD69F1838002 Q38052154-562A136D-A55E-4980-8118-23F86960DA01 Q38189138-640F1D2E-0BAF-4FAC-92F9-4DA4DD7800AF Q38191561-94010BB1-14E7-4339-8D41-26FA458D7C64 Q38192048-DB88DCE0-CBB2-4532-A2FD-5B60E582958C Q38193901-33C61018-7E4E-4235-B80C-1B0D10E1DAD4 Q38545062-4BCBB976-E2D0-4F33-BAD6-AC17EDCD4952 Q38810529-BCAAD5BD-F354-4F6F-AFF9-97AB7DC5B8CE Q38899859-783CBDE2-71FD-4073-94D1-6A3DB9B8855A Q39031805-CCD3577D-359B-428C-BD04-4223F47DE3DB Q39376100-6ADCCEAD-DFB7-4974-8935-13F5D122F4EE Q40961305-0917EE70-61E4-4D8F-8A8A-AE69266BDE79 Q41208488-B63ACD6B-2D84-4F61-86C4-703B9E777516

P2860

Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome.

http://www.wikidata.org/entity/Q34606239

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Decreased expression of seroto ...... with irritable bowel syndrome.

@ast

Decreased expression of seroto ...... with irritable bowel syndrome.

@en

Decreased expression of seroto ...... with irritable bowel syndrome.

@nl

type

label

Decreased expression of seroto ...... with irritable bowel syndrome.

@ast

Decreased expression of seroto ...... with irritable bowel syndrome.

@en

Decreased expression of seroto ...... with irritable bowel syndrome.

@nl

prefLabel

Decreased expression of seroto ...... with irritable bowel syndrome.

@ast

Decreased expression of seroto ...... with irritable bowel syndrome.

@en

Decreased expression of seroto ...... with irritable bowel syndrome.

@nl

P1433

Q34606239-2F2E0726-9B4A-4DF6-9CC4-9466EA171027

P1476

Q34606239-F2E86449-6C57-4CDB-8999-C5F37236419A

P2093

Q34606239-5D547BC3-BED0-40F2-B59B-16FDC804B3DB

Q34606239-67D270D4-8CF2-496F-A8B3-2BB61E462FA5

Q34606239-6955AA3B-F649-45AC-BC6E-331326000D75

Q34606239-A2F2E688-86C8-4F7D-B047-C407069E2946

Q34606239-C7E8C2CE-EADE-42EF-AD9E-E22806872D1C

Q34606239-C8EAE917-E610-4017-86C2-3811D55E3078

Q34606239-FE95AC7B-D8E6-4C86-AC6A-5D0059338B74

P2860

Q34606239-0E4C22E8-A131-4733-9CBA-950C92626C77

Q34606239-101AA80B-A538-4DFD-98FA-4423180AC68A

Q34606239-2F1D0718-0D2B-4558-8D7A-807EDC65A006

Q34606239-3974E583-0668-4C26-ACA5-7E1E0C029EFE

Q34606239-3D143F9C-CF78-4657-AAF2-4527D0B1213D

Q34606239-52EDFA3F-0B8C-4BBF-A41A-EC4D60827282

Q34606239-59328DEE-6C67-4B17-A15A-A857845DD4F1

Q34606239-5D1FF6F1-B1BF-469C-B27E-275E55F438C5

Q34606239-622195EE-203D-4FF8-B6AA-C08DC4F92DD8

Q34606239-6496DEE8-811E-49AA-B895-B2480AE8BC3D

P304

Q34606239-424D99A0-EE59-4F75-9FAF-A30CC73B10F0

P31

Q34606239-F54E9A5C-86A7-431C-B64F-5282AE92D1BA

P356

Q34606239-0A0E180C-C454-4274-B7BF-D592A0F54005

P407

Q34606239-A3E76D80-52DF-4EB8-A286-444E7F5F3392

P433

Q34606239-621F4DAF-1D09-4465-A5B4-859B8FBE4168

P478

Q34606239-CACC5457-6810-49FE-A2E4-2B3349CA7387

P577

Q34606239-CD21F35A-7868-4644-BACF-E6A3A9280549

P5875

Q34606239-442D5D27-9C9D-43E1-B902-920AD862D8DA

P698

Q34606239-B2104C06-F843-43F4-A264-4F9E510AA472

P921

Q34606239-957a28eb-539a-4584-bb79-acd646f3ae46

Q34606239-C4AA73FB-396E-4E28-AD25-42C123FDA34C

Q34606239-DEDB0302-8F27-4601-9D40-7BAFD4657CBE

P932

Q34606239-D537A538-53D4-4D28-A34B-2ED0ED2E8126

P356

P1433

World Journal of Gastroenterology

P1476

Decreased expression of seroto ...... with irritable bowel syndrome.

@en

P2093

Jin-Yan Luo

http://www.w3.org/2001/XMLSchema#string

Jun Gong

http://www.w3.org/2001/XMLSchema#string

Lei Dong

http://www.w3.org/2001/XMLSchema#string

Lu Li

http://www.w3.org/2001/XMLSchema#string

Shen-Hao Wang

http://www.w3.org/2001/XMLSchema#string

Shui-Ping Han

http://www.w3.org/2001/XMLSchema#string

Xiao-Lan Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Functional bowel disorders

Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits.

Review article: intestinal serotonin signalling in irritable bowel syndrome.

Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study

AGA technical review on irritable bowel syndrome.

Role of serotonin in the pathophysiology of the irritable bowel syndrome.

Innervation of mucosal immune cells in the gastrointestinal tract.

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome.

Functional gastrointestinal disorders and mast cells: implications for therapy.

P304

6041-6047

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.13.6041

http://www.w3.org/2001/XMLSchema#string

P407

P433

45

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5824268

http://www.w3.org/2001/XMLSchema#string

P698

18023097

http://www.w3.org/2001/XMLSchema#string

P921

P932

4250888

http://www.w3.org/2001/XMLSchema#string